Dr. Alrifai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 Luther Ln
Ste 2200
Park Ridge, IL 60068Phone+1 847-268-8200Fax+1 847-318-2905
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Ascension Illinois/Saint Joseph (Chicago)Chief Residency, Internal Medicine, 2019 - 2020- Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 2016 - 2019
Damascus University Faculty of MedicineClass of 2014
Certifications & Licensure
IL State Medical License 2016 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 15 citationsBreast implant-associated anaplastic large-cell lymphoma and the role of brentuximab vedotin (SGN-35) therapy: A case report and review of the literature.Kristin Richardson, Taha Alrifai, Kelly Grant‐ Szymanski, George J. Kouris, Parameswaran Venugopal
Molecular and Clinical Oncology. 2017-04-01 - 31 citationsImpact of cachexia on outcomes in aggressive lymphomasReem Karmali, Taha Alrifai, Ibtihaj Fughhi, Ronald Ng, Vineela Chukkapalli
Annals of Hematology. 2017-04-17 - 3 citationsTransfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Man with Heavily Pretreated Intermediate-2 Risk Primary Myelofibrosis.Nicole K Yun, Taha Alrifai, Ira J Miller, Jamile M Shammo
Case Reports in Oncology. 2022-02-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
